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A B S T R A C T
The International Agency for Research on Cancer has classiﬁed one type of multi-walled carbon nanotubes
(MWCNTs) as possibly carcinogenic to humans. However, the underlying mechanisms of MWCNT- induced
carcinogenicity are not known. In this study, the genotoxic, mutagenic, inﬂammatory, and ﬁbrotic potential of
MWCNTs were investigated. Muta™Mouse adult females were exposed to 36 ± 6 or 109 ± 18 μg/mouse of
Mitsui-7, or 26 ± 2 or 78 ± 5 μg/mouse of NM-401, once a week for four consecutive weeks via intratracheal
instillations, alongside vehicle-treated controls. Samples were collected 90 days following the ﬁrst exposure for
measurement of DNA strand breaks, lacZ mutant frequency, p53 expression, cell proliferation, lung inﬂamma-
tion, histopathology, and changes in global gene expression. Both MWCNT types persisted in lung tissues 90 days
post-exposure, and induced lung inﬂammation and ﬁbrosis to similar extents. However, there was no evidence of
DNA damage as measured by the comet assay following Mitsui-7 exposure, or increases in lacZ mutant fre-
quency, for either MWCNTs. Increased p53 expression was observed in the ﬁbrotic foci induced by both
MWCNTs. Gene expression analysis revealed perturbations of a number of biological processes associated with
cancer including cell death, cell proliferation, free radical scavenging, and others in both groups, with the largest
response in NM-401-treated mice. The results suggest that if the two MWCNT types were capable of inducing
DNA damage, strong adaptive responses mounted against the damage, resulting in eﬃcient and timely elim-
ination of damaged cells through cell death, may have prevented accumulation of DNA damage and mutations at
the post-exposure time point investigated in the study. Thus, MWCNT-induced carcinogenesis may involve
ongoing low levels of DNA damage in an environment of persisting ﬁbres, chronic inﬂammation and tissue
irritation, and parallel increases or decreases in the expression of genes involved in several pro-carcinogenic
pathways.
1. Introduction
Multi-walled carbon nanotubes (MWCNTs) are increasingly in-
corporated into diverse manufactured products because of their high
tensile strength, ﬂexibility, adsorption capability, durability and light
weight [1]. As a result, exposure to these materials in environmental
and occupational settings, or via consumer products, is increasing.
Variants of MWCNTs diﬀer in wall numbers, wall thickness, ﬁber
length, rigidity, and chemical impurities. The primary target organ for
toxicological eﬀects following exposure to MWCNTs is the lungs and
uptake via the oral route is low [2,3]. Because of their size, MWCNTs
have unrestricted access to most parts of the lung, can reach highly
vascularised alveolar regions, interstitium and the pleural space, and
exhibit a high degree of pulmonary biopersistence. In experimental
animals, exposure to MWCNTs via inhalation, aspiration or in-
tratracheal instillation [4–7] causes pulmonary inﬂammation, bronch-
iolar and alveolar hypertrophy, interstitial ﬁbrosis, and granuloma
formation [6–11].
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Some studies have reported carcinogenic eﬀects in abdominal cav-
ities and bone marrow cells following intraperitoneal MWCNT exposure
[12–16], and in the lungs of Imprinting Control Region mice following
intratracheal instillation [17]. MWCNTs induce mesothelioma in tumor
prone +/− P53 mice [14,15] and Fisher rats [13]. It is important to
note that no data on human cancer following exposure to MWCNTs is
available at present. A few studies have reported tumours in animal
models exposed to Mitsui-7, a type of long straight MWCNTs at high
doses. However, the results are inconsistent [18]. For other MWCNT
types, data is not available. Based on the results of animal studies, the
International Agency for Research on Cancer (IARC) has classiﬁed
Mitsui-7 as possibly carcinogenic to humans (Group 2B) [19]. Indeed,
Mitsui-7 was recently shown to induce lung cancer in a rat inhalation
study [20]. Thus, there is some evidence that MWCNTs are carcino-
genic. However, the underlying mechanisms are largely unknown and
systematic research in this direction is urgently needed.
It has been suggested that thin and longer versions of MWCNTs
induce cancer via mechanisms similar to other high-aspect ratio ﬁbers
such as asbestos. The mechanisms of toxicity associated with asbestos-
induced cancer are attributed to speciﬁc ﬁbre characteristics that in-
clude biopersistence, length, and rigidity [21]. Studies have shown that
rigid MWCNTs such as Mitsui-7 exhibit a higher potential to induce
cancer than the tangled MWCNTs [7,22,23]. Several in vitro studies
[24–26] as well as an in vivo study [27] have shown that MWCNTs
induce oxidative stress. Thus, oxidative damage of genetic material may
be one mechanism by which MWCNTs initiate and/or promote cancer.
However, a recent study by Sargent et al. (2014) showed that MWCNTs
may not be directly carcinogenic; rather, it has been proposed that
these materials act as promoters of murine pulmonary carcinogenesis
[28].
Current models of carcinogenesis propose that substance-induced
DNA damage, manifested via direct interaction of toxic substances or
substance metabolite with DNA or indirect generation of DNA-dama-
ging by reactive oxygen species (ROS) contributes to the formation of
mutations, which can serve as initiating events in carcinogenesis. The
accumulation of mutations in speciﬁc oncogenes or tumour suppressor
genes, as well as successful selection and survival of cells harboring
mutations, play important roles in inducing genetic instability and
uncontrolled cellular proliferation, two important hallmarks of cancer
[29]. However, it is not clear if DNA damage and resulting mutations
play a role in the cancers induced by MWCNTs.
In addition to ROS generation and concomitant genotoxicity,
MWCNTs induce both acute and chronic lung inﬂammation, which are
also implicated in the etiology of substance-induced lung cancer [11].
Additionally, several studies have consistently demonstrated the po-
tential of MWCNTs to induce lung ﬁbrosis in experimental animals,
which is also considered to be a precursor event to lung cancer in hu-
mans [30–32]. However, it is unknown if MWCNT-induced lung in-
ﬂammation and ﬁbrosis in experimental animals are indeed key events
that lead to lung cancer. Moreover, the underlying mechanisms by
which lung inﬂammation or lung ﬁbrosis predispose organisms to car-
cinogenesis are not understood.
The study is based on two hypotheses – 1) CNTs are genotoxic and
hence potentially carcinogenic, and 2) CNTs may induce carcinogeni-
city via non-genotoxic mechanisms that may involve lung inﬂammation
and ﬁbrotic injury. The speciﬁc objective of the study was to char-
acterise the genotoxicity, mutagenicity, cellular proliferation, in-
ﬂammatory and ﬁbrosis eﬀects in response to pulmonary MWCNT ex-
posure in a mouse model with an aim to determine whether these are
likely key events in the pathway leading to MWCNT-induced pul-
monary carcinogenesis. The second objective was to identify the func-
tional pathways and networks perturbed to understand the biology that
is impacted and to characterise the molecular mechanisms at play. The
study investigated two individual MWCNTs, Mitsui-7 and NM-401, both
of which are straight and rigid ﬁbres that exhibit similar physico-che-
mical properties. While Mitsui-7 has been categorised by IARC as pos-
sibly carcinogenic, the carcinogenic potential of NM-401 has not been
investigated. To achieve the stated objectives, Muta™Mouse were ex-
posed to vehicle only, Mitsui-7 or NM-401 (two doses per MWCNT
type) once a week for four consecutive weeks via intratracheal in-
stillations, and lungs, collected 90 days after the ﬁrst instillation. Since
pro-carcinogenic changes take time to establish, ninety days post-
Fig. 1. Schematic diagram showing summary of experimental design.
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exposure time point was chosen. The following endpoints were eval-
uated: (a) DNA damage assessed using the comet assay; (b) mutageni-
city assessed by the lacZ transgene mutation assay; (c) inﬂammation
assessed by bronchoalveolar lavage ﬂuid (BALF) cell count; (d) histo-
pathology and immunohistochemistry to measure cellular proliferation,
ﬁbrosis and p53 response; and (e) global changes in gene expression
and pathophysiologic pathways. The experimental design, including the
endpoints assessed, is summarized in Fig. 1.
2. Materials and methods
2.1. Properties of MWCNTs investigated
Two diﬀerent MWCNTs were investigated in this study. The Mitsui
XNRI-MWNT-7 (Mitsui-7; Lot# 05072001K28) was obtained from
Mitsui Company (Tokyo, Japan) (now Hadoga Chemical Industry). NM-
401 was a donation from the European Union Joint Research Centre,
Ispra, Italy. NM-401 is also part of the OECD Working Party on
Manufactured Nanomaterials testing program. The physico-chemical
properties of Mitsui-7 [9,14,33] and NM-401 [6,33,34] have been
published and are summarized in Table 1. Mitsui-7 exhibits tube dia-
meters of 49–100 nm, and lengths of 3–5.7 μm; whereas NM-401 ex-
hibits tube diameters of 30–90 nm, and lengths of 3.6–4.4 μm. The BET
isotherm analysis showed surface areas of 22–26 m2/g for Mitsui-7 and
17.85–18 m2/g for NM-401. Inductively Coupled Plasma Mass Spec-
troscopy (ICP-MS) analysis showed that Mitsui -7 and NM-401 contain
impurities such as iron (Fe), sodium (Na), aluminum (Al). Energy-dis-
persive X-ray spectroscopy (EDS) analysis showed that NM-401 also
contains silica (Si), copper (Cu) and zinc (Zn).
2.1.1. Dose selection
Doses were selected based on the previously published studies on
other nanoparticles [35,36]. Multiple instillations were chosen instead
of a single instillation to increase the eﬃcacy of the study. The total
deposited doses are within the dose ranges used in other instillation or
aspiration studies with carbon nanotubes [9,37–39], but are a physio-
logically high bolus dose in comparison to the NIOSH recommended
occupational exposure limit of 1 μg/m3 [40]. For mice, 45 years of work
life exposure to 1 μg/m3 for 40 h/week would result in 18 μg deposition
with a deposition rate of 10% [41]. On the other hand, work place
measurements of CNTs have been shown to be up to hundreds of times
above the recommended exposure values [42–47]. Although, these are
physiologically high doses, chronic inﬂammation and lung ﬁbrosis has
been observed in mice at these doses of Mitsui-7 and NM-401 [5,6].
Moreover, very high, 436 μg/mouse (Mitsui-7) and 312 μg/mouse (NM-
401) doses were included in the study to determine if exposure to high
doses of MWCNTs results in pulmonary genotoxicity and mutagenicity,
as well as to conduct dose-response assessment of relevant endpoints.
We have previously demonstrated that intratracheal instillation results
in widespread delivery of material in murine lung [48], and that in-
tratracheal instillation of serum dispersed MWCNTs results in delivery
of MWCNTs to all lung lobes in mice [7].
2.1.2. Preparation of MWCNT stock and determination of exposure dose
A stock suspension of each MWCNT type was prepared fresh on the
day of exposure at a concentration of 3.2 mg/mL in NanoPure water
containing 2% serum collected from Muta™Mouse. The particle sus-
pension was dispersed by sonicating the samples using an S-450D so-
niﬁer (Branson Ultrasonics Corp., Danbury, CT, USA) at 10% amplitude
for a total of 16 min on ice with alternating 10 s pulses and pauses.
Sonicated suspensions were diluted to the desired concentrations and
sonicated for an additional 1 min with the same setting before their
administration.
During the stock suspension preparation, it was noted that a fraction
Table 1
Characteristics of Mitsui-7 and NM-401.
MWCNT Code Name Mitsui-7 NM-401
Producer Mitsui' & Company IO-LE-TEC Nanomaterials (CP-0006-SG)
MWCNT Code Name Mitsui-7 (NRCWE-006) NM-401
Tube diameter (TEM), nm 40–90a,74b, 49−100c, 74 ± 28e 10–30a, 67b, 67 ± 26.2d,
64.2 ± 34.5e
Tube length (TEM), μm 5.7 ± 0.49b, 3–5c, 5.7 ± 3.7e 5–15a, 4.0 ± 0.37b, 4.0 ± 2.4d,
4.05 ± 2.4e
Straightness (TEM) Straight Straight
Surface area (BET), m2/g 24–28a,26b, 22e 40–300a,17.85b, 18e
Surface area (SAXs), m2/g > 30
Impurities, % <1a,< 0.5c < 5a,< 3d
Minor Impurity phases (XRD on TGA
residual)e
Fe2O3 ND
SAXS aggregate size [nm]e NA NA
DLS Zeta aggregate size [nm]e NA NA
Minor elements (EDS)e ND Si: 500 ppm, Cu: 2300 ppm, Zn:
Minor elements/coatings (ICP-MS)e Na, Mn, Al, Ni, Mg (Na: 499 ± 103 μg/g, Mg:
1 ± 1 μg/g, Al: 66 ± 19 μg/g, Fe: 355 ± 2 μg/
g, Ni: 1 μg/g)
Na, Mn, Al, Ni, Mg (Na: 581 ± 32 μg/g,
Fe: 379 ± 71 μg/g, Mg: 0 ± 0.3 μg/g,
Al: 59 ± 4 μg/g, Ni: 2 μg/g)
Zeta-size and reactivity in 0.05% BSA watere
DLS Zeta-size BSA medium [nm] 682 ± 13 710 ± 17
24-h dissolution catalyst partially dissolved catalyst partially dissolved
pH reactivity negligible (−)
dO2 Reactivity negligible negligible
Rotating Drum Dustinesse
Inhalable dustiness index NA NA
Respirable dustiness index NA NA
MWCNT: Multiwalled carbon nanotube; TEM: Transmission Electron Microscopy; BET: Brunauer–Emmett–Teller; SAXS: Small-Angle X-ray Scattering; DLS: Dynamic Light Sctattering;
EDS: Energy-dispersive X-ray spectroscopy; ICP-MS: Inductively Coupled Plasma Mass Spectroscopy and BSA: Bovine Serum Albumin.
a Values claimed by manufacturer.
b Values reported by Jackson et al. [33].
c Values reported by Poulsen et al. [5].
d Values reported by Poulsen et al. [6].
e Values reported by NANOGENOTOX Final Report 2013.
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of both types of MWCNTs remained unsuspended at the top of the
particle suspension; this part was removed prior to exposure. In order to
determine the exact exposure dose, the well-suspended portion was
transferred to a new glass tube. Vehicle suspension that did not contain
any MWCNTs was treated similarly. All suspensions were dried in an
oven at 80 °C, and 50 μl vehicle or 1 ml particle suspensions were de-
posited on top of twenty-ﬁve mm glass microﬁber ﬁlters grade GF-C
(Whatman, Sigma-Aldrich) that were acclimatized to a controlled am-
bient environment for 24 h before being weighed on an ultra-ﬁne
analytical balance with 1 μg precision (XP6, Mettler Toledo). Following
the deposition, the ﬁlters were incubated for 22 h at 80 °C and subse-
quently acclimatized for 24 h to ambient environment before being
weighed.
The increase in ﬁlter weight deposited with vehicle-only suspension
was subtracted from the ﬁlters treated with the MWCNT suspension.
The exposure dose per 50 μl volume was then calculated from each
instillation of the stock suspensions for all four weeks. For Mitsui-7 the
doses were 36 ± 6 μg/mouse (low dose) and 109 ± 18 μg/mouse
(high dose), and for NM-401 the doses were 26 ± 2 μg/mouse (low
dose) and 78 ± 5 μg/mouse (high dose).
2.2. Animal handling and exposure
Adult 12 week old female Muta™Mouse were used in the study. The
Muta™Mouse is a transgenic mouse (strain 40.6) with 29 ± 4 stably-
integrated, concatenated copies of a non-transcribed λgt10lacZ shuttle
vector [49,50] that contain a target transgene (i.e., lacZ) for determi-
nation of induced mutant frequency. The Muta™Mouse system has been
employed to score induced in vivo mutations in over 30 tissues, and
indeed, it has been used to assess the mutagenicity of over 300 test
articles [51,52]. The mice are bred and maintained at Health Canada,
Ottawa, Canada.
The mice were individually housed in plastic ﬁlm isolators, pro-
vided with water and food ad libitum (2012 Teklad Global standard
rodent diet), and maintained under a 12 h light/12 h dark cycle. The
mice were randomly divided into ﬁve experimental groups consisting of
12 mice per group: 0 (i.e., control mice exposed to vehicle only, shared
between the two particle types), 36 ± 6 or 26 ± 2 μg/mouse (i.e.,
low dose), and 109 ± 18 or 78 ± 5 μg/mouse (i.e., high dose) for
Mitsui-7 and NM-401, respectively. Mice within each treatment group
were exposed via intratracheal instillation once a week for four con-
secutive weeks. In a separate experiment, ﬁve additional mice per
treatment group were exposed using the same treatment regimen with
the sole purpose of collecting lung tissues for histopathological ana-
lyses.
The mice were anesthetized with 5% isoﬂuorane until relaxed, and
were kept under 2.5% isoﬂuorane during the instillation process.
During the entire procedure, the mice were held inclined at a 45 ° angle
on their backs. Each instillation consisted of 50 μl MWCNT suspensions
followed by 150 μl air, which was administered with a 250 μl SGE glass
syringe (250F-LT-GT, SGE Analytical Science, Australia). Vehicle con-
trol exposure consisted of 50 μl 2% serum prepared in NanoPure water
followed by 150 μl air. Following instillation, animals were kept under
observation until recovery from anesthesia before moving them to their
respective cages.
Ninety days following the ﬁrst exposure the mice were anesthetized
by isoﬂuorane and sacriﬁced by cardiac puncture. Blood, BALF and
lung tissues were collected. For transcriptomic analyses, lung tissues
were collected after lavage. Post-lavage, the left and the right lobes of
the lungs from exposed and control mice were cut into pieces, snap
frozen in liquid nitrogen, and stored in cryogenic vials at −80 °C until
analysis. All the analyses except transcriptomics were conducted in
blind.
All animal procedures were conducted according to the guidelines
for the care and handling of laboratory animals established by the
Canadian Council for Animal Care Guidelines, and all protocols were
approved by the Animal Care Committee of Health Canada.
2.3. Histopathology
For histopathological examinations, lung cross sections were pre-
pared from 5 mice per treatment group (i.e., control, low dose, high
dose) for each particle type. Lungs from control, Mitsui-7 or NM-401
exposed mice were uniformly inﬂated at 30 cm H2O pressure with 10%
formalin. Following 24 h of formalin ﬁxation, lungs were dehydrated
with graded alcohol, and paraﬃn embedded. 4-mm thick lung slices
were cut. The resulting slides were stained with hematoxylin and eosin
(H & E) to measure pathological changes and collagen deposition was
assessed by Masson Trichrome stain. Images were acquired and ana-
lyzed using a Ziess-Axioskope-2 microscope (Carl Zeiss, Germany). A
previously published guideline on International Harmonization of
Nomenclature and Diagnostic Criteria (INHAND) was used to classify
lung lesions [53]. Additionally, immunohistochemistry for the ﬁbro-
blast marker vimentin, proliferation marker Ki67 and tumour sup-
pressor p53 was also performed on formalin-ﬁxed, paraﬃn embedded
lung tissue sections. Ki67 and vimentin immuno-staining of lung sec-
tions was performed using kits, and according to the manufacturer’s
instruction (MACH 4 Universal HRP-Polymer Kit with DAB kit, Biocare
Medical LLC, USA). Heat-induced epitope retrievals were performed at
110 °C for 12 min with citrate buﬀer (pH 6.0) prior to staining. In order
to prevent endogenous peroxidases, 3% H2O2 was used. Incubations
with primary Ki67 (BioCare Medical, Catalogue #CRM 325 A, 1:500
dilution) and Rabbit vimentin antibodies (Cell Signaling, Catalogue
#5741, Clone D21H3, 1:100 dilutions) were conducted for 1 h at am-
bient temperature.
For detecting p53 expression, the Peroxidase Anti Peroxidase (PAP)
technique was applied as described in previous studies [54,55]. Brieﬂy,
antigen retrieval was performed prior to staining by heating the lung
sections in a microwave oven. Endogenous peroxidase activity and non-
speciﬁc binding were blocked using 3% H2O2 in methanol and normal
swine serum, respectively. The slides were incubated with monoclonal
mouse anti-human p53 protein DO-7 (DAKO, Denmark) at 1:1000 di-
lution followed by incubation with rabbit anti-mouse immunoglobulin.
Finally, the slides were treated with PAP complex and Di-aminobenzi-
dine (DAB) before proceeding with imaging using a Perkin Elmer Vectra
microscope (PerkinElmer, Waltham, MA).
Select sections were stained with Periodic acid Schiﬀ-hematoxylin
(PASH) to detect mucus production [56,57], Perls’ Prussian blue con-
taining 20% hydrochloric acid and 10% potassium ferrocyanide for
15 min, and nuclear fast red counter stain to detect iron homeostasis.
For quantiﬁcation of ﬁbrotic lesions, a series of images (using a
1.25x objective) of the entire longitudinal cross-section of the lungs
from H& E stained lung sections were used. The disease area was de-
ﬁned by thickened alveolar septa, which also corresponded with areas
of collagen deposition as determined by the Masson Trichrome staining.
The disease area was traced and measured using Image J software
(National Institute of Health, Bethesda, MD) and expressed as a per-
centage of the total cross-sectional area. Similarly, semi-quantitative
analysis of Masson Trichrome and vimentin stain was conducted to
determine the total collagen deposition and ﬁbroblast proliferation in
lungs, respectively. For Masson Trichrome and Vimentin, 5 individual
images (using a 10x objective) were captured from each lung section
from 5 mice.
2.4. Dark ﬁeld and hyperspectral mapping of MWCNTs in lung sections
Haematoxylin and eosin stained lung sections were used for hy-
perspectral mapping of MWCNTs. Darkﬁeld images of lung sections
were captured at 100× magniﬁcation using a Cytoviva unit (Cytoviva,
Inc., Auburn, AL) integrated onto an optical microscope. Hyperspectral
images (HSI) were captured as previously described [36] using the HSI
unit ENVI 4.8 software and mapped to the hyperspectral libraries for
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the MWCNTs. The maximum acceptable angles between the known and
unknown spectra were not greater than 0.1 rad.
In order to determine the orientation and localisation of MWCNTs
within the lung tissue, 3D images of MWCNTs in lungs were captured.
The Cytoviva Enhanced Dark Field Microscope equipped with a piezo-
driven Z-axis stage, a dual mode ﬂuorescence module, and Cytoviva’s
image acquisition and control software was used to acquire and store a
stack of equally spaced images of the sample at 100× magniﬁcations.
At this magniﬁcation, the spatial resolution of the image pixel in the XY
direction was 64.5 nm. Direct light from the dual mode ﬂuorescence
module was used to capture the images of the MWCNTs; light passing
through a multi-pass ﬁlter was applied to capture the images of the
surrounding tissue. The z resolution was set to 200 nm. The stack of
images of the MWCNTs and the surrounding tissue were collapsed using
the Cytoviva 3D Image Analysis Image J plugin via interpolation and
deconvolution, respectively, in order to obtain 3D renderings. The 3D
renderings were viewed with the 3D viewer in the Image J plugin.
2.5. Comet assay
DNA strand breaks were determined on frozen BALF cell suspen-
sions and lung tissues (3 × 3 × 3 mm). Twelve mice from each group
were lavaged twice with 1 ml of 0.9% sterile saline using an en-
dotracheal tube with a 1 or 2 ml syringe to obtain BALF. The BALF was
immediately put on ice until cells were separated by centrifugation at
4 °C and 400g for 10 min. The BALF cells were re-suspended in 0.5 ml
PBS. Organ samples were snap frozen at dissection, and kept at−80 °C
to −60 °C until analysis. The nucleoid preparation and automated
comet analysis has previously been described in detail [58]. Brieﬂy,
frozen tissues were repeatedly pressed through a stainless steel cy-
lindrical sieve (diameter 0.5 cm, mesh size 0.4 mm) into 1.5 ml ice-cold
Merchant’s medium. BAL cells and lung preparations were embedded in
agarose (0.7% ﬁnal concentration) and cast on TREVIGEN 20-well
comet slides. These were immersed into 4 °C lysing solution and re-
frigerated overnight. The following day, samples were alkaline treated
and subjected to alkaline electrophoresis (pH > 13) in ice cold circu-
lating electrophoresis solution. Samples were neutralized, ﬁxed, and
later stained by SYBR Green. Comets were scored by the automated
PathFinder system (IMSTAR, France). DNA strand breaks were quan-
tiﬁed as the comet tail length (TL) and the% DNA in the comet tail (%
tail DNA).
The comet experiment included eleven 20-well slides each of which
included A549 cells as negative (treated with PBS for 30 min at 4 °C)
and positive controls (treated with 60 mM H2O2 for 30 min at 4 °C). All
slides with the same tissue were run in the same electrophoresis elim-
inating day-to-day or electrophoresis variation.
The variation in the results (% DNA in the tail and tail length) from
the three control samples was 12–16% (negative control), 12–17%
(positive control 30 and 60 mM).Statistical signiﬁcance compared to
control sample were determined by conducting non-parametric one-
way ANOVA with a post- hoc Tukey-type analysis. A positive response
was deﬁned as a statistically signiﬁcant increase in the% tail DNA in at
least one dose group in comparison with the vehicle control.
2.6. LacZ mutant frequency analysis
Transgene (lacZ) mutant frequency was determined using the P-gal
(phenyl-β-D-galactopyranoside) positive selection assay as described
previously [7,51,52,59,60]. The λgt10lacZ DNA was rescued from
genomic DNA using the Transpack® packaging system (Agilent Tech-
nologies, Mississauga, Ontario). The packaged phage particles were
mixed with host bacterium (Escherichia coli lacZ−, galE−, recA−, pA-
A119 with galT and galK), plated on minimal medium containing 0.3%
(w/v) P-Gal, and incubated overnight at 37 °C. Total plaque-forming
units (pfu) were measured on concurrent plates that did not contain P-
Gal. Mutant frequency was expressed as the ratio of the number of
mutant pfu to total pfu, as described previously [51]. Statistical sig-
niﬁcance compared to control sample were determined by conducting
non-parametric one-way ANOVA with a post- hoc Tukey-type analysis.
2.7. BALF analysis
The BALF samples were prepared as described previously [61].
Cytospins were ﬁxed with two sprays of Sheldon Cell Fix, air dried, and
stained with hematoxylin and eosin (H and E). At least 500 cells were
counted per cytospin to identify mononuclear cells, neutrophils, and
lymphocytes using an optical microscope (Olympus BH2, Olympus
Optical Company Ltd, Tokyo, Japan) according to standard mor-
phology. Percentage of each cell component was calculated and mul-
tiplied by the total cell number to determine the number of each cell
component.
A Two-way ANOVA was conducted for each BALF component (i.e.,
diﬀerent cell types) to examine the eﬀect of particle type and dose
(Origin version 8, Northampton, MA). Pair-wise comparisons with
Bonferroni correction were conducted when signiﬁcant interactions
were observed.
2.8. Total RNA extraction and puriﬁcation
Total RNA was isolated from random sections of the left lungs
(n = 5 per experimental group) using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA), and puriﬁed using RNeasy Plus Mini kits (Qiagen,
Mississauga, ON, Canada) according to the manufacturer’s instruction.
Total RNA concentration was measured using a NanoDrop 2000 spec-
trophotometer (Thermo Fisher Scientiﬁc Inc., Wilmington, DE, USA),
and RNA quality and integrity was assessed using an Agilent 2100
Bioanalyzer (Agilent Technologies, Mississauga, ON, Canada) according
to the manufacturer’s instruction. All samples had RNA integrity
numbers above 7.0.
2.9. Microarray hybridization
Total RNA (250 ng) from individual mice (n = 5 per experimental
or control group) and Universal Mouse Reference total RNA (UMRR)
(Agilent Technologies, Mississauga, ON, Canada) were used to synthe-
size double-stranded cDNA. Cyanine-labelled cRNAs were synthesized
from the cDNA using Quick Amp Labeling Kit (Agilent Technologies,
Mississauga, ON, Canada) according to the manufacturer’s instructions.
cRNAs from control and MWCNT-treated samples were labelled with
Cyanine 5-CTP, and reference cRNAs were labelled with Cyanine 3-CTP
using a T7 RNA polymerase in vitro transcription kit (Agilent
Technologies, Mississauga, ON, Canada) and puriﬁed using RNeasy
Mini kits (Qiagen, Mississauga, ON, Canada). An equimolar amount of
reference cRNA was mixed with each experimental cRNA sample and
was hybridized to Agilent mouse 8 × 60 k oligonucleotide microarrays
(Agilent Technologies Inc., Mississauga, ON, Canada) for 17 h in a hy-
bridization chamber at 65 °C with a rotation speed of 10 rpm. Following
hybridization, arrays were scanned on an Agilent G2505B scanner ac-
cording to manufacturer’s protocols. Gene expression data from the
scanned images were extracted using Agilent Feature Extraction soft-
ware version 9.5.3.1.
2.10. Statistical analysis of microarray data
A reference randomized block design was used to analyse gene ex-
pression microarray data. Data were normalized using LOcally
WEighted Scatterplot Smoothing (LOWESS) regression modeling
method and statistical signiﬁcance of the diﬀerentially expressed genes
was determined using MicroArray ANalysis Of VAriance (MAANOVA)
[62] in R statistical software (http://www.r-project.org). The Fs sta-
tistic [63] was used to test the treatment eﬀects compared to the control
vehicle, and p-values were estimated by the permutation method using
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residual shuﬄing. In order to minimize any false positives, the false
discovery rate (FDR) multiple testing correction [64] was applied. The
fold changes of gene expression were calculated considering the least-
square means. Genes showing expression changes of at least 1.5-fold in
either direction compared to their matched controls, and with FDR p-
values of less than or equal to 0.05 (p≤ 0.05) were considered sig-
niﬁcantly diﬀerentially expressed, and were used in all downstream
analyses. All microarray data have been deposited in the NCBI gene
expression omnibus database and can be accessed via the accession
number GSE75429.
2.11. Functional and pathway analysis of diﬀerentially expressed genes
Functional gene ontology (GO) analysis of the diﬀerentially ex-
pressed genes (DEGs) was performed using the Database for
Annotation, Visualization and Integrated Discovery (DAVID) v6.7 [65].
Benjamini-Hochberg corrected GO processes with a Fisher’s exact
p≤ 0.05 were considered to be signiﬁcantly enriched (i.e., over-re-
presented). Speciﬁc biological pathways associated with the diﬀeren-
tially expressed genes were identiﬁed using Ingenuity Pathway Analysis
(IPA, Ingenuity Systems, Redwood City, CA, USA). Pathways with a
Fisher’s exact p-value≤ 0.05 were considered for discussion.
3. Results
3.1. Physico-chemical properties of the MWCNTs used
The physico-chemical properties of Mitsui-7 [9,14,33] and NM-401
[6,33,34] are summarized in Table 1. The length and diameter of NM-
401 used in the present study was characterised as part of European
Union joint action NANOGENOTOX project. Mitsui-7 and NM-401 ex-
hibit tube diameters of 74 ± 28 nm and 64.2 ± 34.5 nm, and lengths
of 5.7 ± 3.7 μm and 4.05 ± 2.4 μm, respectively. The BET isotherm
analysis showed surface areas of 22 m2/g for Mitsui-7 and 18 m2/g for
NM-401. Thus, both MWCNT are relatively thick, long and have<5%
impurities.
3.2. Hyperspectral mapping of MWCNTs in lung sections
Hyperspectral mapping was conducted to determine whether
Mitsui-7 or NM-401 persist in lung tissue 90 days post-exposure. In a
hyperspectral image each pixel contains spectral information of that
spatial pixel area. Thus, comparison between the tissue spectral proﬁles
of hyperspectral images of Mitsui-7 or NM-401 in lung with the re-
ference spectral libraries created for Mitsui-7 or NM-401 allowed lo-
calization and identiﬁcation MWCNTs in lung. The darkﬁeld images
and corresponding mapped hyperspectral images of tissues exposed to
vehicle only, Mitsui-7 or NM-401 at low and high doses are represented
in Fig. 2a–e and in Fig. 2f–j, respectively. The areas of the hyperspectral
images that matched to reference spectral libraries of Mitsui -7 or NM-
401 in lung tissue are colored in blue and indicated by white arrow
heads. The reference spectral libraries of Mitsui -7 or NM-401 in lung
tissue, or as suspension in water, after background subtractions are
represented in Fig. 2k–n. The hyperspectral mapping of MWCNTs re-
vealed that notable amount of Mitsui-7 and NM-401 were retained in
lung tissue even 90 days following the ﬁrst exposure in both dose
groups. Bimodal peaks were observed for the MWCNTs in the tissue
matrix with predominant peaks at approximately 590 nm for Mitsui -7
(Fig. 2k) and 610 nm for NM-401 (Fig. 2m), and minor peaks at ap-
proximately 480 nm (Fig. 2k and m). Broader predominant peaks at
approximately 550–650 nm were observed in the spectral libraries of
Mitsui -7 or NM-401 as suspensions in water (Fig. 2l and n). Broad
distributions of peak positions suggest non-homogeneities. The shifts in
the peak positions between the reference spectral libraries and the
MWCNT in the tissue matrix indicate changes in morphologies of these
agglomerates as a result of interactions with tissue [66] over the 90 day
Fig. 2. Hyperspectral mapping of Mitsui -7 or NM-401 in lung tissue after 90 days of last exposure. The white arrows pointing towards the blue stained area represents MWCNTs.
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period. Visualization of the full rendering using 3D cytoviva (Supple-
mentary movie 1) conﬁrmed that the MWCNTs are in direct contact
with the lung cells at the time of necropsy.
3.3. BALF and lung tissue genotoxicity and mutagenicity assessment
DNA damage was assessed in BALF and lung by quantifying DNA
damage using the comet assay. The data, which are presented as tail
length (TL) and tail% DNA, did not show any signiﬁcant increase in
DNA damage in the BALF of MWCNT-exposed mice relative to vehicle-
exposed mice (Fig. 3, top panel). Similarly, no signiﬁcant changes were
observed in Mitsui-7-exposed lungs compared to matched controls.
However, a signiﬁcant increase in DNA strand breaks was observed in
lungs of mice treated with high doses of NM-401 (Fig. 3, bottom panelb,
Supplementary Table I) as measured by both comet parameters –TL and
tail% DNA (18 ± 1.05 and 6.1 ± 1.63 versus 24 ± 2.42 and
12.7 ± 1.86 for high dose NM-401 and control, respectively). The
errors here represent standard error mean.
Transgene (lacZ) mutant frequency (MF) analysis was used to de-
termine the mutagenic potential of MWCNTs. Mean MF frequency for
the control mice was 6.8 ± 0.7 × 10−5. Mice exposed to Mitsui-7 or
NM-401 did not show statistically signiﬁcant increases in the levels of
transgene MF (6.1 ± 0.3 × 10−5 or 6.4 ± 0.5 × 10−5, respectively)
compared to control (Fig. 4) at any doses 90 days post-ﬁrst exposure.
3.4. Cellular proliferation
Select lung tissue sections were analyzed for Ki-67 expression to
examine the eﬀects of MWCNT exposure on cell proliferation. Increased
Fig. 3. DNA strand break levels determined using the Comet assay; (A) Tail length and (B) % tail DNA in BALF and in lung tissue from mice exposed to Mitsui -7 or NM-401 at low or high
dose 90 days after last exposure. The statistical signiﬁcance of the response in exposed group compared to matched vehicle controls was determined by a non-parametric one-way ANOVA
with a post- hoc Tukey-type experimental comparison test. * indicates that the response is signiﬁcantly diﬀerent (p value≤ 0.05) from the matched control.
The box plots illustrate median (black lines), mean (■), and data points (▲). *Statistically diﬀerent from vehicle instilled mice at P≤ 0.05. Box limits indicate the 75th nd 25th
percentiles.
Fig. 4. Transgene lacZ mutation frequency in lung tissues from animals exposed to Mitsui
-7 or NM-401 at low or high dose after 90 days of last exposure. The statistical sig-
niﬁcance of the response in exposed group compared to matched vehicle controls was
determined by a non-parametric one-way ANOVA with a post- hoc Tukey-type experi-
mental comparison test. NS − not signiﬁcantly diﬀerent from vehicle control. The box
plots illustrate median (black lines), mean (■), and data points (▲).Box limits indicate
the 75th nd 25th percentiles.
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cellular proliferation compared to the matched control was observed for
the low dose (Fig. 5A–b, g) and the high dose (Fig. 5A–c, h) Mitsui-7
treated lung sections. Cellular proliferation induced by NM-401 was
comparable to that of the matched controls (Fig. 5A–d, i) in the low
dose group, but higher compared to the matched control in the high
dose group (Fig. 5A–e, j). Increased staining for Ki-67 was observed
mainly near the bronchiolar ducts in these dose group animals.
3.5. p53 expression
Expression of p53 was investigated only in the high dose groups.
Increased p53 expression was observed in the lung sections exposed to
high doses of Mitsui-7 (Fig. 5B–b, e) and NM-401 (Fig. 5B–c, f), com-
pared with control lung tissue sections (Fig. 5B–a, d). The p53 staining
was predominantly found in the areas of ﬁbrotic lesions, and was
comparatively higher in the NM-401 exposed group.
3.6. Lung inﬂammation and ﬁbrosis
3.6.1. BALF cell count
BALF from eight mice for the control group and six mice for each of
the exposed groups was assessed for diﬀerential inﬂammatory cell
counts (Fig. 6 and supplementary Table II a–b). At 90 days post-ex-
posure, the total number of cells was∼7- and∼4.6-fold higher in BALF
from mice exposed to Mitsui-7 or NM-401, respectively, compared to
the vehicle exposed mice (Fig. 6a). A similar trend was found for
macrophages (Fig. 6b).
The cellular proﬁle shown in Fig. 6c revealed an increase in the
number of neutrophils following MWCNT exposure. Speciﬁcally, there
was a 134- and 160-fold increase in neutrophils following exposure to
low and high doses of Mitsui-7, respectively, and a 76- and 100-fold
increase following exposure to low and high doses of NM-401, respec-
tively, compared to matched controls (Supplementary Table IIb). The
number of lymphocytes also increased by 67- and 60-fold following
exposure to Mitsui-7, and by 12- and 20-fold following exposure to NM-
401 at the low and high doses, respectively (Fig. 6d; Supplementary
Table IIb).No signiﬁcant diﬀerence was observed in the eosinophil
counts for control and MWCNT-exposed samples (Fig. 6e). The total
number of epithelial cells was 10- and 14-fold higher in low and high
dose Mitsui-7 exposed groups, respectively, and 3- and 5-fold higher in
low and high dose NM-401 exposed groups compared to their matched
controls, respectively (Fig. 6f, Supplementary Table IIb). The trends
between the BALF cellular proﬁles of mice exposed to Mitsui-7 or NM-
401 were comparable except for the total neutrophil and epithelial
cells.
3.6.2. Histopathology
In accordance with the hyperspectral mapping results, histopatho-
logical analysis of H-E stained MWCNT-exposed lung tissues showed
that signiﬁcant amounts of MWCNTs were still present (Fig. 7A a–e) in
the lungs 90 days post-exposure. MWCNTs were frequently found in
bundles mainly in the ﬁbrotic foci. The granulomatous lesions in
MWCNT-exposed group were dominated by macrophages. Lesions oc-
curred mainly, but not exclusively, in the centriacinar areas (CA), or at
Fig. 5. Immunohistochemical detection of Ki67 (a–e, at 10×magniﬁcation and f-j at 20 x magniﬁcation) in lung tissues from animals exposed to Mitsui -7 or NM-401 at low or high dose,
90 days after the last exposure. Dark brown nuclear staining indicates increased levels of Ki67 expression. Arrowheads show area of elevated cellular proliferation, (arrowhead). (B)
Immunohistochemical detection of p53 (a–c, at 10× magniﬁcation and d-f at 20× magniﬁcation) in lung tissues from animals exposed to Mitsui -7 or NM-401 at low or high dose,
90 days after the last. Dark brown nuclear staining indicates increased levels of p53 expression.
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the junctions of the terminal bronchioles and alveolar ducts (Fig. 7A
a–e, Supplementary Table III). Quantiﬁcation of the diseased area
showed signiﬁcant increase in disease area in MWCNT-exposed lungs
compared to vehicle treated lungs from matched controls (Fig. 7A–a).
The lung sections were stained with Masson Trichrome stain (blue
area) to assess collagen deposition, an indicator of ﬁbrotic lesions.
Minimal to mild collagen deposition (1.2% of the total area, 7B-b) was
found in the vehicle treated lungs (Fig. 7A–f); more speciﬁcally, in the
vascular and bronchiolar interstitium and the walls of the alveolar
ducts. In the MWCNT-exposed mice, the amount of collagen was
modestly increased to 2–2.6% (Fig. 7A g–j, 7B–b), with deposition in
the walls or interstitium of alveolar ducts, alveoli, and airways. Mild
collagen deposition was also observed in alveolar regions near the in-
ﬂammatory cells and within the granulomas. Immunohistochemistry
using an antibody against vimentin, a marker of ﬁbroblasts, showed
increased vimentin staining (1–1.2% of the total area (brown stain),
Fig. 7B–c), in the MWCNT-exposed lung sections (Fig. 7A l–o); more
speciﬁcally, in the areas of ﬁbrosis in the high dose NM-401 group,
which had the greatest vimentin staining (Fig. 7A–o). In contrast, ve-
hicle treated controls (Fig. 7A–k) showed minimal vimentin staining
(0.6% of the total area, 7B–c). Staining of lung sections with PAS, a
marker for mucin production, showed increased mucin synthesis (black
arrowheads) in the areas of airway epithelium (Supplementary
Fig. 1a–e) in lungs exposed to both types of MWCNTs at all tested doses,
relative to the vehicle exposed lungs. Additional staining for iron con-
tent using Prussian blue showed minimal staining of macrophages in
lungs exposed to MWCNTs. One mouse showed signiﬁcant increases in
iron positive macrophages compared to vehicle-treated controls (Sup-
plementary Fig. 1f–j).
3.6.3. Gene expression analysis
A list of DEGs (i.e., up- and downregulated genes) from samples
collected 90 days post-exposure to Mitsui-7 or NM-401, relative to ve-
hicle control, is presented in Supplementary Table IV. Fig. 8A sum-
marizes the number of up- and downregulated genes for all dose-par-
ticle type combinations.
Mitsui-7 induced 1372 DEGs (i.e., 902 upregulated and 470 down-
regulated) and 1411 DEGs (i.e., 958 upregulated and 453 down-
regulated) in mouse lungs in the low and high dose groups, respec-







































































Fig. 6. Diﬀerential cell counts 90 days post-exposure in Bronchoalveolar Lavage Fluid (BALF) from animals exposed to vehicle control or Mitsui -7 or NM-401. The errors here represent
standard error mean. * indicates that the response is signiﬁcantly diﬀerent at the 0.05 level. The response to each dose/MWCNT combination was determined by conducting two-Way-
ANOVA. Post-hoc pair-wise comparisons, with the appropriate Bonferroni correction, were applied following a signiﬁcant interaction to examine the eﬀect of each dose/MWCNT
combination. NI: no interaction between particle and dose main eﬀects; †: signiﬁcant interaction between dose and particle main eﬀects; NS: non-signiﬁcant.
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the chloride channel calcium activated 3 (Clca3, 172- and 153-fold
increases for the low and high dose, respectively), chemokine (C-X-C
motif) ligand 5 (Cxcl5, 8- and 4-fold), serum amyloid A 3 (Saa3, 25- and
19-fold), chemokine (C-C motif) ligand 7 (Ccl7, 13- and 10-fold), trig-
gering receptor expressed on myeloid cells 2 (Trem2, 13- and 13-fold),
glycoprotein (transmembrane) nmb (Gpnmb, 12- and 16-fold), Spp1 (16-
and 20-fold), lymphocyte antigen 6 complex, locus I, interferon (Ly6i,
8- and 6-fold), alpha-inducible protein 27 like 2A (Iﬁ27l2a, 6- and 4-
fold), mucin 5, subtype B, tracheobronchial (Muc5b, 11- and 12-fold)
and ﬁbrinogen gamma chain (Fgg, 6- and 9-fold). There were 1073
DEGs (i.e., 731 up- and 342 downregulated) that were in common be-
tween the low and high dose groups (Fig. 8B–a) for both Mitsui 7 and
NM-401, respectively.
The number of DEGs (1205) in the low dose NM-401 group was
comparable to the low dose Mitsui-7 group (1372 DEGs) with 874
common DEGs between the two MWCNT groups (Fig. 8B–b). However,
at the high dose, there was a large increase (214%, 2585 DEGs, 1459
upregulated and 1126 downregulated) in the number of DEGs in the
NM-401 exposed lung samples compared to the high dose Mitsui-7
group (1411 DEGs). The largest expression changes compared to ve-
hicle controls were observed for Clca3 (62-, 177-fold), Cxcl5, (17- and
12-fold), Saa3 (17- and, 53-fold), Ccl7 (11-, 25-fold), Trem2 (11-, 25-
fold), Gpnmb (10- and, 32-fold), Spp1 (7- and 30-fold), Ly6i (9- and 8-
fold), Iﬁ27l2a (9- and, 13-fold), Muc5b (9-, 13-fold) and Fgg (9- and 14-
fold) genes in the low and high doses of NM-401, respectively. There
were 978 DEGs (i.e., 679 up- and 299 downregulated) in common to
dose groups of NM-401 (Fig. 8B–c). A total of 1199 DEGS (i.e., 781 up-
and 418 downregulated) were aﬀected by both MWCNTs in the high
dose group (Fig. 8B–d).
Although the genes showing the largest expression changes for NM-
401 were the same as the ones observed in the Mitsui-7 groups, the
expression changes in the NM-401 exposed mice showed a clear dose-
dependent response and exhibited larger fold changes than the Mitsui-7
group. However, the response was not dose-dependent for all genes,
and higher expression was often observed in the low dose group com-
pared to the high dose.
Enrichment analysis for GO terms showed that pulmonary exposure
to Mitsui-7 and NM-401 induced perturbation in many biological pro-
cesses (Fig. 9) at both doses including: immune response
(GO:0006955), inﬂammatory response (GO:0006954), homeostatic
process (GO:0042592), lymphocyte activation (GO:0046649), antigen
processing and presentation (GO:0019882), cell adhesion
(GO:0007155), myeloid leukocyte activation (GO:0002274), and cell
proliferation (GO:0008283) (Fig. 9A). These biological processes are
associated with inﬂammation and ﬁbrosis. Biological processes en-
riched in Mitsui-7 or NM-401 exposed lungs at the high dose only in-
cluded: acute inﬂammatory response (GO:0002526), regulation of cy-
tokine production (GO:0001817), ion homeostasis (GO:0050801),
skeletal system development (GO:0001501), epithelium development
(GO:0060429), extracellular structure organization (GO:0043062), os-
siﬁcation (GO:0001503), regulation of cytoskeleton organization
(GO:0051493), complement activation-classical pathway
Fig. 7. (A) Histopathological images (10× magniﬁcation) of H and E, Mason Trichrome, and vimentin stained lung tissues from animals exposed to Mitsui -7 or NM-401 at low or high
dose, 90 days after last exposure. The ﬁgures illustrate the presence of carbon nanotubes in tissue: red arrows (a–o), granuloma: black arrowhead (a–e), normal level of collagen
deposition: blue coloured areas, increased level of collagen deposition: black arrows (f–j), and increased ﬁbroblast proliferation: blue arrows (k–o). (B) Results of semi-quantitative
analysis of the disease area (a), total collagen deposition (b), and total ﬁbroblast proliferation (c). The response to MWCNT at each dose was compared to the matched control by two
paired t-test. * indicates that the response is signiﬁcantly diﬀerent from the vehicle control (p value ≤0.05).
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(GO:0006958), and cell death (GO:0008219) (Fig. 9B). In addition,
biological processes associated with DNA damage (intracellular sig-
naling cascade (GO:0007242), apoptosis (GO:0006915), angiogenesis
(GO:0001525), regulation of MAPKKK cascade (GO:0043408), ATP
metabolic process (GO:0046034), response to oxidative stress
(GO:0006979), anti-apoptosis (GO:0006916) and regulation of DNA
binding (GO:0051101)) were also perturbed in treated lungs at the high
doses.
Global gene expression and ingenuity biological functions analysis
revealed perturbations of a vast number of biological functions in re-
sponse to both particle types. While inﬂammatory response and related
functions were among those functions predominantly aﬀected, other
processes related to ﬁbrosis (e.g., connective tissue disorders), cancer
(e.g., cytotoxicity, cell viability, advanced malignant tumor, metastasis,
and invasion of tumor), arthropathy and cardiovascular diseases, were
also signiﬁcantly (p-values< 5 × 10−8) impacted. The results of the
pathway analysis showing the top impacted diseases and functions
associated with the DEGs in lung samples exposed to Mitsui-7 or NM-
401 at both doses are presented in Supplementary Fig. 2A. The number
of DEGs associated with these pathways and functions was higher in
lungs exposed to NM-401 than Mitsui-7.
In order to understand disease mechanisms, canonical pathways
were analysed using IPA (Supplementary Fig. 2B). Most signiﬁcantly
perturbed pathways were associated with inﬂammation, hepatic ﬁ-
brosis and oxidative damage, and genes in these pathways were en-
riched in both MWCNT groups. The number of genes and the fold
changes of DEGs associated with the ﬁbrosis and DNA damage path-
ways was higher in NM-401 than Mitsui-7 exposed mouse lungs.
Several upstream regulators had fold change values above 1.3, and
the activation state and signiﬁcance of a regulator were predicted from
the Z-score calculated in IPA. An upstream regulator with a positive Z-
score was considered to be potentially activated, whereas an upstream
regulator with a negative Z-score was considered to be potentially in-
hibited. An upstream regulator with a Z-score≥ 2 was considered to be
Fig. 8. (A) Signiﬁcant diﬀerentially expressed genes
(FDR p value ≤0.05) in lung tissues from animals
exposed to Mitsui -7 or NM-401 at low or high dose,
90 days after the last exposure; (B) Venn diagram
showing the comparisons between the numbers of
DEGs at 90 days post-exposure in low and high dose
groups of Mitsui -7 (a), low dose groups of Mitsui and
NM-401 (b), low and high dose groups of NM-401 (c)
and high dose groups of Mitsui -7 and NM-401 (d).
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signiﬁcant. Upstream regulators Tnf, interleukin 6 (Il6), Myd88, colony
stimulating factors (Csf1 and Csf2), interferon regulatory factor 7 (Irf7),
Jun oncogene (Jun), insulin-like growth factor I (Igf1), nitric oxide
synthase 2 (Nos2), Cd44, chemokine (C-C motif) ligand 2 (Ccl2), BCL2-
associated X protein (Bax) and secreted phosphoprotein 1 (Spp1) were
signiﬁcantly activated (Supplementary Fig. 2C) in lung samples exposed
to Mitsui-7 and NM-401 in both dose groups. The interleukin 10 re-
ceptor-alpha (Il10ra), atypical chemokine receptor 2, (Ackr2), sup-
pressor of cytokine signaling 1 (Socs1) and apolipoprotein E precursor
(Apoe) appeared to be inhibited (Z- score ≤2) in these groups. In ad-
dition, Mitsui-7 in the low and high dose groups and NM-401 in the
high dose group inhibited regulation of prostaglandin E receptor 4
(Ptger4). However NM-401 inhibited regulation of interleukin 1 re-
ceptor antagonist (Il1rn).
A list of genes associated with inﬂammation and ﬁbrosis was com-
piled using the Qiagen mouse RT2 proﬁler Pathway-speciﬁc PCR array,
and the MWCNT-induced gene list published in Poulsen et al., 2015 [6].
Similarly, we compiled a lung cancer gene list using the genes present
on the Qiagen mouse RT2 proﬁler array, and the MWCNT-induced 35
cancer gene signature reported in [67]. These lists were used to assess
number of DEGs in lungs exposed to Mitsui -7 or NM-401 that are as-
sociated with inﬂammation, ﬁbrosis and cancer (Fig. 10A–D). Fol-
lowing Mitsui -7 exposure, a total of 61 and 58 DEGs were associated
with inﬂammation in the low and high dose groups, respectively
(Fig. 10A and B), and 45 and 42 DEGs were associated with ﬁbrosis in
the low and high dose groups, respectively (Fig. 10A and B). Among the
ﬁbrotic genes, 37 genes in the low dose group (Fig. 10A) and 35 genes
in the high dose group (Fig. 10B) were common to DEGs associated
with inﬂammation. There were 27 DEGs in the low dose group
(Fig. 10A) and 29 DEGs in the high dose group (Fig. 10B) that were
associated with cancer, 8 of which were common to inﬂammation and
ﬁbrosis in each dose group (Fig. 10A–B).
For the NM-401 exposure, a total of 61 and 75 DEGs were associated
with inﬂammation (Fig. 10C and D), and 42 and 55 DEGs were asso-
ciated with ﬁbrosis at the low and high doses, respectively (Fig. 10C
and D). Among the ﬁbrotic genes, 37 DEGs in the low dose group
(Fig. 10C) and 42 DEGs in the high dose group (Fig. 10D) were also
associated with inﬂammation. There were 29 DEGs in the low dose
Fig. 9. Signiﬁcant diﬀerentially perturbed biological pathways (p value
≤0.05) for Mitsui -7- or NM-401-treated lung tissues, which were common
to all dose groups (A), and only perturbed in high dose groups (B) 90 days
after the last exposure.
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group (Fig. 10C) and 39 DEGs in the high dose group (Fig. 10D) that
were associated with cancer; 7 of these DEGs in the low dose group
(Fig. 10C) and 9 in the high dose group (Fig. 10D) were common to
inﬂammation and ﬁbrosis. Approximately 20% of the ﬁbrotic DEGs
induced by Mitsui -7 or NM-401 (e.g., matrix metallopeptidase 12
(Mmp12), matrix metallopeptidase 14 (Mmp14), chemokine (C-X-C
motif) ligand 10 (Cxcl10), insulin-like growth factor 1 (Igf1), inter-
leukin 6 (Il6) and Ptk2) are also associated with cancer.
4. Discussion
In the present study, the transgenic Muta™Mouse system was used
to investigate the ability of two rigid and straight MWCNT types
(Mitsui-7 and NM-401) to induce in vivo DNA damage (i.e., strand
breaks), transgene mutations, inﬂammation, cellular proliferation, p53
expression, global gene expression changes following multiple pul-
monary exposures, in an attempt to elucidate the underlying mechan-
isms of potential carcinogenesis caused by these materials.
Observations at 90 days post-exposure to four instillations of Mitsui-7, a
type of MWCNT categorised by IARC as possibly carcinogenic to hu-
mans (2B), did not reveal any signiﬁcant increase in DNA damage. No
mutations were observed in the lacZ gene in lung tissue. In comparison,
NM-401, another type of MWCNT, not classiﬁed as carcinogenic, in-
duced signiﬁcant DNA damage in mouse lungs in the 78 ± 5 μg/mouse
dose group at the same time point; however, it did not induce mutations
in the lacZ gene in lung tissue.
Depending on the type of MWCNTs, doses, and post-exposure time
points investigated, the literature pertaining to induced DNA damage,
such as strand breaks (i.e., comet results), is variable. The comet assay
has been previously used to demonstrate that rigid and long MWCNTs
can induce DNA strand breaks. For example, Poulsen et al. (2015)
showed that NM-401 (straight and rigid ﬁber), but not NRCWE 026
(tangled ﬁber), induced DNA damage in lungs of animals collected
1 day after intratracheal exposure [6]. Similar results showing in-
creased DNA strand breaks and adducts were observed in mice exposed
to Mitsui-7 via intratracheal instillation [17], and DNA strand breaks in
BALF of mice exposed to Mitsui-7 via inhalation [68]. Another study
[69] showed signiﬁcant DNA damage at human oxoguanine DNA gly-
cosylase 1 (hOGG1)- and formamidopyrimidine DNA glycosylase (FPG)-
sensitive sites (i.e., indicative of oxidative DNA lesions), but no sig-
niﬁcant increase in DNA damage in the lungs of Apolipoprotein E-deﬁ-
cient (ApoE−/−) mice following 10 intratracheal instillations of
Mitsui-7 (i.e., 4 or 40 μg/mouse per week for 10 weeks). However NM-
401 did not show DNA damage in A549, BEASE-2B and FE-1[33,70].
It has been shown that Mitsui-7 can increase gpt mutant frequencies
in lungs of gpt delta transgenic mice 56 days after 4 repeated in-
tratracheal instillation of 200 μg/mouse for four weeks [17]. On the
other hand, single or double instillations did not induce a signiﬁcant
increase in gpt mutant frequencies. In addition, the Pig-a mutation as-
says in the bone marrow and the gpt delta mutation assays in lungs did
not show an increase in mutations of F344/NSlc-Tg (gpt-delta) male rats
administered a single intratracheal instillations of Mitsui-7 (1 mg/kg)
[71]. In vitro, exposures of Chinese hamster lung cells to Mitsui-7 also
did not induce signiﬁcant increases in hypoxanthine-guanine phos-
phoribosyltransferase (hgprt) mutations, micronuclei or chromosome
aberrations [72]. Mutagenic eﬀects of NM-401 have not very much
been documented. In one study, in vitro exposure of Chinese hamster
lung (V79) ﬁbroblasts to NM-401 induced hgprt mutations [73]. One of
Fig. 10. Network showing direct and indirect interactions between signiﬁcant diﬀerentially expressed genes (FDR p value≤0.05) associated with lung inﬂammation, ﬁbrosis and cancer.
Expression changes observed in lung tissues from animals exposed to Mitsui -7 or NM-401, at low or high dose, 90 days after the last exposure.
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the limitations of the present study is that the post-exposure recovery
period may be too short and may not be ideal to capture the mutations.
A large fraction of the instilled CNT dose will remain in the lungs for
more than a year [74], and it could be hypothesized that the observed
pulmonary genotoxicity caused by NM-401 would develop into muta-
tions following a longer post exposure period. However, at present, no
international guidelines are available to investigate the genotoxic ef-
fects of MWCNTs, and the overall evidence regarding the mutagenicity
of MWCNTs is scarce and inconsistent. These results suggest that more
studies are needed to conclusively assess the in vivo genotoxic abilities
of MWCNTs.
From the results, it can be construed that some types of MWCNTs
have the potential to induce DNA strand breaks; however, several fac-
tors including the strain of mice investigated, dose regimen, mode of
exposure and post-exposure time points for sampling employed may all
have signiﬁcant inﬂuence on the study conclusions. Although NM-401
induced DNA damage at the high dose tested, there was no evidence for
gene mutations. It is a possibility that persistent MWCNTs (as observed
by the microscopic analysis) leading to chronic tissue injury and cell
death may have eﬀectively removed the cells containing mutated genes
before they were ﬁxed leading to no changes in the overall mutant
frequency in lacZ gene. The present study did not investigate chromo-
somal aberrations and micronuclei, other markers of genotoxicity and
thus, the true implications of the observed DNA strand breaks on the
lung remains unclear. However, there are studies in the literature that
have investigated induction of chromosomal aberrations and micro-
nuclei formation following exposure to MWCNTs. Authors [75] showed
that industrial MWCNT graphistrength do not show any chromosomal
damage or micronuclei formation in bone marrow of rats at 90 day
post- exposure following nasal inhalation at dose of 5 mg/m3. On the
other hand, unmodiﬁed MWCNTs at a dose of 2–10 mg/kg body weight
[76] and COOH functionalized MWCNT at a dose of 0.75 mg/kg body
weight [16] were shown to induce chromosomal damage in bone
marrow cells of Swiss Albino mice. NM-401 also induced chromosomal
damage in A549 but not in BEAS-2B or in human lymphocytes [70,77].
COOH functionalized MWCNT were shown to induce dose dependent
mitotic spindle damage in immortalized respiratory epithelial cells
(BEAS-2B) at dose of 0.024–24 μg/cm2 [78]; however, unmodiﬁed
MWCNT did not induce any chromosomal damage in BEAS-2 B at a
dose of 5–80 μg/cm2 [79]. As mentioned above, it is also a possibility
that MWCNTs are clastogens that induce disruption or breakage of
chromosomes leading to rearrangement, large deletions or additions in
chromosomes, a form of mutagenesis leading to genetic instability and
cancer. However, this study has not investigated the clastogenic eﬀects
of MWCNTs. Thus, additional studies involving time series analysis and
diﬀerent genotoxic endpoints may help delineate the genotoxic eﬀects
of MWCNTs; moreover, elucidate the underlying mechanisms. It has
been suggested that the underlying mechanisms of particle-induced
genotoxity may not be the same as chemical-induced genotoxicity [75].
Genotoxicity may result from the direct interaction of substances with
DNA, or from indirect eﬀects including ROS synthesised by in-
ﬂammatory cells during the substance-induced inﬂammation in lungs.
Although there hasn’t been evidence supporting the claim that
MWCNTs are genotoxic carcinogens, it is clear from the studies de-
scribed above that MWCNTs induce robust chronic lung inﬂammation
involving multiple inﬂammatory cell types resulting in ROS generation
and subsequent DNA damage. Although it can be argued that DNA
damage may not be necessary for MWCNT-induced carcinogenesis, it
can also be hypothesised that MWCNTs that induce both chronic in-
ﬂammation and sustained DNA damage are more potent carcinogens
(https://www.niehs.nih.gov/news/newsletter/2015/9/spotlight-
mixtures/). Recently, IARC recognised 10 key characteristics of carci-
nogens, which included ability to induce chronic inﬂammation and
tissue irritation [80], both of which are known to be the hallmark
consequences of MWCNT exposure. The others include electrophilic
nature, ability to induce genotoxicity, aﬀect DNA repair mechanisms,
induce oxidative stress, aﬀect epigenetics, immunospressive, modulate
receptor-mediated signalling, disrupts cell cycle, and cell proliferation
[80].
Non-genotoxic carcinogens include substances that act as tumor
promoters, endocrine disruptors, receptor mediators, immune sup-
pressors, or inﬂammogenic and tissue damaging agents [81] and may
act via disruption of cellular structures and vesicles (lysosomal de-
gradation), increased cellular proliferation or by modulating the pro-
cesses involved in DNA repair or in the maintenance of genetic stability.
Here, we show that MWCNTs persist in lungs long after the exposure is
terminated. Moreover, our results show that chronic lung inﬂammation
and markers of lung ﬁbrosis are found 90 days post-exposure. These can
in turn cause increased ROS synthesis and chronic tissue injury that
may be predisposing factors for carcinogenesis. Furthermore, the gene
expression analysis was extended to identify focus molecules or DEGs
that are highly connected to the biological processes and/or disease
related networks available in the IPA database. Our results showed that
cancer was the top ranking IPA network perturbed with 31 focus mo-
lecules in lung tissues exposed to Mitsui-7 at the lowest dose. Cancer,
cell death and survival, and ROS generation were among the top net-
works, ranked 4th, 3rd, and 16th, respectively, perturbed in lung tissues
exposed to high dose Mitsui-7 with 28, 29, and 24 focus molecules,
respectively. Cancer, cell death and survival, and ROS generation were
also among the top 25 networks, ranked 23rd, 25th, and 21st, respec-
tively, perturbed in lung tissues exposed to low dose NM-401 with 21,
20, and 21 focus molecules, respectively. Cancer was the 12th ranked
network with 31 focus molecules in lung tissues exposed to NM-401 at
high dose. Regardless of the genetic toxicity results, the results clearly
indicate that the two types of MWCNTs examined induced a signiﬁcant
enrichment of genes involved in cancer pathways and networks.
A detailed analysis of the tissue-wide gene expression changes
showed that genes associated with scavenging free radicals such as,
BCL2-like 14 (apoptosis facilitator,Bcl2l14), betaine-homocysteine me-
thyltransferase 2 (Bhmt), cytochrome b-245, beta polypeptide (Cybb),
Epstein-Barr virus induced gene 3 (Ebi3), c-fos induced growth factor
(Figf), insulin-like growth factor binding proteins (Igfbp1, Igfbp6), in-
sulin-like 6 (Insl6), neutrophil cytosolic factors (Ncf1,Ncf2,Ncf4),
NADPH oxidase 4 (Nox4), NADPH oxidase organizer 1 (Noxo1), on-
costatin M receptor (Osmr), platelet-derived growth factor, C polypep-
tide (Pdgfc), prominin 1 (Prom1), trefoil factor 2 (spasmolytic protein 1)
(Tﬀ2), transmembrane protein with EGF-like and two follistatin-like
domains 2 (Tmeﬀ2) were signiﬁcantly diﬀerentially expressed in lungs
of animals exposed to the high dose of Mitsui-7 and both doses of NM-
401, suggesting perturbation of the redox status following exposure to
MWCNTs. The signiﬁcant alteration in ROS counteracting genes is
supportive of the observed DNA strand break results for NM-401
groups. Although, ROS can cause DNA strand breaks and mutations
[60,82,83], repairs of the DNA lesions and breaks by repair enzymes at
an early stage can prevent associated mutagenic activity [84]. As de-
scribed above, it is also possible that cells with damaged DNA are
committed to apoptosis, hence DNA damage was not observed in
Mitsui-7 groups in spite of signiﬁcant alteration of ROS counteracting
genes. Indeed, expression of several genes that are involved in cell
death were altered by both MWCNT types including: (a) upregulation of
mucosa associated lymphoid tissue lymphoma translocation gene 1
(Malt1), caspase 1 (Casp 1), caspase 4 (Casp 4), NIMA Related Kinase 6
(Nek6), cell death-inducing DFFA-like eﬀector b (Cideb), programmed
cell death 1 (Pdcd1), B-cell leukemia/lymphoma 2 related protein A1c
(Bcl2a1), PYD and CARD domain (Pycard), baculoviral IAP repeat-
containing (Birc), growth arrest and DNA-damage-inducible 45 gamma
(Gadd45 g), NLR family, apoptosis inhibitory protein 2 (Naip2), and
clusterin (Clu); and (b) downregulation of GATA zinc ﬁnger domain
containing 2A (Gatad2a), cell death eﬀector c (Cidec), tumor necrosis
factor receptor superfamily, member 1b (Tnfrsf1b), Fas apoptotic in-
hibitory molecule 2 (Fame2) and endothelin converting enzyme 1 (Ece
1). Moreover, high levels of p53 expression were observed in the
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ﬁbrotic lesions of lungs in mice exposed to NM-401 showing signiﬁcant
increases in DNA strand break levels. p53 expression may be upregu-
lated as a response to DNA damage caused by apoptosis. Our gene ex-
pression analysis showed signiﬁcant diﬀerential expression of proa-
poptotic Noxa1 and Bax, which can be induced in a p53 mediated
apoptotic pathway [85]. Increased p53 expression in the ﬁbrotic re-
gions suggests the vulnerability of the disease foci for genetic damage
and possible carcinogenic transformation if defence mechanisms such
as p53 activation fail. Activation of p53 pathway is suggested to have a
role in contributing tissue damage [86]. Increased p53 expression and
ﬁbrotic lesions were also observed in Mitsui-7 exposed lung despite
clear evidence of DNA damage; however p53 expression was much
lower in Mitsui-7 exposed lungs compared to NM-401 exposed lungs.
Genes from the mucin family were also altered following exposure
to both types of MWCNTs. Membrane associated mucins, and both se-
creted gel forming and non-gel forming mucins, are involved in forming
physical barriers, protecting and repairing epithelia against environ-
mental toxins [87]. Elevated expression of membrane associated mucin,
Muc4, secreted gel forming mucins Muc5b and Muc5ac occurred fol-
lowing exposure to selected doses of Mitsui-7 and NM-401 (i.e., high
and low). However, Muc1 was downregulated in all the experimental
groups. Muc4 is thought to promote tumorigenesis through its epi-
dermal growth factor (EGF)-like domain [88,89]. Increased expression
of Muc5b is observed in the early stages of mucinous lung adenocarci-
noma [90–92]. Upregulation of Muc4, Muc5b and Muc5ac and down-
regulation of Muc1 is correlated with p53 mediated suppression of
growth arrest by promoting apoptotic target [91]. In our study, histo-
pathological analysis showed airway epithelial mucous metaplasia in
lungs exposed to Mitsui-7 or NM-401 at all doses. These results suggest
that even if the two MWCNT types were capable of inducing DNA da-
mage, strong counteracting responses mounted against the generated
ROS, and eﬃcient and timely elimination of damaged cells through cell
death, may have prevented accumulation of DNA damage and hence
mutations at the post-exposure time point investigated. However, par-
allel increases or decreases in the expression of genes involved in cell
survival, cell proliferation, anti-apoptotic processes, angiogenesis,
combined with perturbations of the associated functions/pathways in
tissues containing persistent ﬁbres that manifest chronic inﬂammation
and tissue irritation, may all enable creation of carcinogenic environ-
ment and ultimately carcinogenesis.
5. Conclusions
This study showed that repeated instillations of high doses of
Mitsui-7 and NM-401, representing straight rigid carbon nanoﬁbers, do
not induce DNA mutations in transgenic MutaMouse at 90-days post-
exposure. DNA strand breaks were only observed in lungs of animals
exposed to NM-401, and not Mitsui-7. The observed DNA strand breaks
in NM-401 were accompanied by increased p53 expression, which was
speciﬁcally localised to ﬁbrotic lesions, implying potential vulnerability
of the ﬁbrotic tissue to DNA damage. Neither DNA damage, nor p53
activation was observed in Mitsui-7 exposed mouse lungs to the same
extent as that observed in the NM-401 group. However, both MWCNTs
induced robust and chronic inﬂammation and ﬁbrotic lesions in lungs.
More importantly, both MWCNTs induced changes in the expression of
hundreds of genes associated with hallmarks of cancer – cellular process
involved in maintenance of cell homeostasis as well as activation of
carcinogenic transformation. The results also indicated that a subset of
DEGs associated with inﬂammation and ﬁbrosis are also linked to
cancer. More studies involving chronic exposures to low doses of
MWCNTs, with investigations of induced alterations in cellular activ-
ities related to DNA repair, activation of cellular death cascades, and
other neoplastic transformation processes are necessary to fully ap-
preciate the carcinogenic potential of toxic ﬁbres such as MWCNTs.
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